Rational development of peptide vaccination in clinical oncology.
Keiholz
U
U
Scheibenbogen
C
C
Theil
E
E
Schadendorf
D
D
D000951:Antigens, Neoplasm; D002986:Clinical Trials as Topic; D006801:Humans; D016233:Immunotherapy, Active; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009363:Neoplasm Proteins / Q000276:immunology*; D012878:Skin Neoplasms / Q000276:immunology / Q000628:therapy*; D016896:Treatment Outcome; D022223:Vaccines, Subunit / Q000276:immunology / Q000627:therapeutic use*
D000951:Antigens, Neoplasm; C072013:MAGEA3 protein, human; D009363:Neoplasm Proteins; D022223:Vaccines, Subunit